Literature DB >> 25147604

Total Synthesis and Biological Studies of TMC-205 and Analogues as Anticancer Agents and Activators of SV40 Promoter.

Yang Gao1, Sami Osman1, Kazunori Koide1.   

Abstract

TMC-205 is a natural fungal metabolite with antiproliferative activity against cancer cell lines. The light- and air-sensitivity prevented in-depth exploitation of this novel indole derivative. Herein, we report the first synthesis of TMC-205. On the basis of its reactivity with reactive oxygen species, we developed air-stable analogues of TMC-205. These analogues are 2-8-fold more cytotoxic than TMC-205 against HCT-116 colon cancer cell line. Importantly, at noncytotoxic dose levels, these analogues activated the transcription of luciferase reporter gene driven by simian virus 40 promoter (SV40). Further, these small molecules also inhibit firefly luciferase, presumably by direct interaction.

Entities:  

Keywords:  TMC-205; firefly luciferase; gene activation; indole,; natural product; simian virus 40 promoter

Year:  2014        PMID: 25147604      PMCID: PMC4137371          DOI: 10.1021/ml500025p

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

1.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.

Authors:  H Ueda; H Nakajima; Y Hori; T Fujita; M Nishimura; T Goto; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1994-03       Impact factor: 2.649

2.  New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  H Nakajima; B Sato; T Fujita; S Takase; H Terano; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

Review 3.  Inducible gene expression systems for higher eukaryotic cells.

Authors:  M Gossen; A L Bonin; S Freundlieb; H Bujard
Journal:  Curr Opin Biotechnol       Date:  1994-10       Impact factor: 9.740

Review 4.  Allylstannanes and vinylstannanes from stannylcupration of C-C multiple bonds. Recent advances and applications in organic synthesis.

Authors:  Asunción Barbero; Francisco J Pulido
Journal:  Chem Soc Rev       Date:  2005-09-13       Impact factor: 54.564

Review 5.  Chemical and biochemical aspects of superoxide radicals and related species of activated oxygen.

Authors:  A Singh
Journal:  Can J Physiol Pharmacol       Date:  1982-11       Impact factor: 2.273

6.  Prenylindoles from Tanzanian Monodora and Isolona species.

Authors:  Mayunga H H Nkunya; John J Makangara; Stephan A Jonker
Journal:  Nat Prod Res       Date:  2004-06       Impact factor: 2.861

7.  Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter.

Authors:  Natasha Thorne; Min Shen; Wendy A Lea; Anton Simeonov; Scott Lovell; Douglas S Auld; James Inglese
Journal:  Chem Biol       Date:  2012-08-24

8.  A comparison of bovine growth-hormone gene expression in mouse L cells directed by the Moloney murine-leukemia virus long terminal repeat, simian virus-40 early promoter or cytomegalovirus immediate-early promoter.

Authors:  A Martin-Gallardo; M Montoya-Zavala; B Kelder; J Taylor; H Chen; F C Leung; J J Kopchick
Journal:  Gene       Date:  1988-10-15       Impact factor: 3.688

9.  GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp. I. Taxonomy, production, isolation, physicochemical properties and biological activities.

Authors:  Yasushi Sakai; Tetsuo Yoshida; Keiko Ochiai; Youichi Uosaki; Yutaka Saitoh; Futoshi Tanaka; Tadakazu Akiyama; Shiro Akinaga; Tamio Mizukami
Journal:  J Antibiot (Tokyo)       Date:  2002-10       Impact factor: 2.649

Review 10.  The spliceosome as target for anticancer treatment.

Authors:  R J van Alphen; E A C Wiemer; H Burger; F A L M Eskens
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.